ISSN 1662-4009 (online)

ey0021.13-13 | Identifying Health Disparities and Improving Access to Healthcare | ESPEYB21

13.13. Refocusing the World Health Organization's model list of essential medicines on the needs of low and middle income countries

VJ Wirtz , AL Gray , S Sharma , J Sun , HV Hogerzeil

Brief Summary: This commentary argues to refocus the WHO Model List of Essential Medicines on the needs of low and middle-income countries, reiterating the original goals of the process to promote equitable access to medicine and improve health globally.The World Health Organization (WHO) Model List of Essential Medicines, first published in 1977, is designed to promote equitable access to essential medicines that address the priority health needs of pop...

ey0016.13-1 | Diabetes | ESPEYB16

13.1. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial

PC Rockers , RO Laing , PG Ashigbie , MA Onyango , CK Mukiira , VJ Wirtz

Lancet Glob Health 2019;7: e492–502. DOI: 10.1016/S2214-109X(18)30563-1• The authors evaluated the effect of a Novartis programme that provides metformin at a wholesale price of US$1 per month in Kenya.• This cluster-randomized controlled trial significantly increased the availability of metformin at health facilities, but not at patient househ...